Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global In Silico Clinical Trials Market Size study, by Industry (Medical Devices, Pharmaceutical) by Therapeutic Area (Oncology, Infectious Disease, Hematology, Cardiology, Dermatology, Neurology, Diabetes, Others) by Phase (Phase I, Phase II, Phase III, Phase IV) and Regional Forecasts 2022-2028

  • BIZ4982692
  • 200 Pages
  • May 2022
  • Healthcare
Download Sample    Get Discount   
 
Global In Silico Clinical Trials Market is valued approximately USD 2.51 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2028. The use of individualized computer simulation in the development or regulatory review of a medicinal product, medical equipment, or medical intervention is referred to as in silico clinical trials. Clinical trials involving animals and humans have a higher risk of negative effects. In silico clinical trials lower the risk of adverse reactions during trials, hence boosting the research study's safety and efficacy. Furthermore, technical improvements in in silico clinical trials are increasing its market demand. When compared to in silico trials, traditional clinical trials are substantially more expensive. A clinical trial might cost anywhere between USD 4 million and USD 20 million, according to Sofpromed, a clinical research business. As a result, one of the key factors driving the development of computer-based trials is the high cost of traditional clinical trials. Furthermore, in silico trials provide for a better knowledge of a drug's or device's safety and efficacy, as well as a reduction in the likelihood of clinical studies being terminated, lowering trial costs. There has been a huge increase in R&D expenditure for drug development in recent years. For example, according to a Congressional Budget Office report (US) on pharmaceutical R&D, the pharmaceutical industry's R&D spending have climbed from USD 38 billion in 2000 to USD 83 billion in 2019. The increase in R&D spending is expected to have a beneficial effect on market growth. Because of the COVID-19 pandemic, clinical research sites were temporarily shut down, increasing need for in silico clinical trials for research investigations. Clinical research has been disrupted as a result of the COVID-19 epidemic, which has sparked renewed interest in using computer simulations to anticipate clinical trial outcomes. The pandemic had resulted in a worldwide need for medicines and vaccinations. Traditional studies take a long time and cost a lot of money; to solve this problem, researchers used computer simulation trials to validate COVID-19 medicines and vaccines. However, throughout the projected period of 2021-2027, the market's expansion would be hampered by the high cost of methods and procedures.

The key regions considered for the global In Silico Clinical Trials Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America had the highest revenue share. In the United States, a large number of in silico trials are being done. Furthermore, the presence of significant businesses in the region such as GNS Healthcare Inc., Insilico Medicine, Inc., Immunetrics Inc., and others has contributed to regional market growth. Over the projection period, Asia Pacific is expected to be the fastest-growing regional market. The Asia Pacific market is still in its infancy. In silico trials are being used by a number of companies in this region to minimise the overall cost of clinical trials. For example, in November 2021, DSTC, a Japanese preclinical CRO, teamed with InSilicoTrials to use in silico clinical trials to revolutionise the drug development process.

Major market player included in this report are:

Certara, Inc.

Novadiscovery Sas

Insilico Medicine, Inc.

Dassault Systemes SE

GNS Healthcare Inc.

The AnyLogic Company

InSilicoTrials

Immunetrics Inc.

Nuventra Pharma Sciences

Abzena Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Industry:

Medical Devices

Pharmaceutical

By Therapeutic Area:

Oncology

Infectious Disease

Hematology

Cardiology

Dermatology

Neurology

Diabetes

Others

By Phase

Phase I

Phase II

Phase III

Phase IV

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global In Silico Clinical Trials Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. In Silico Clinical Trials Market, by Region, 2020-2028 (USD Billion)

1.2.2. In Silico Clinical Trials Market, by Industry, 2020-2028 (USD Billion)

1.2.3. In Silico Clinical Trials Market, by Therapeutic Area, 2020-2028 (USD Billion)

1.2.4. In Silico Clinical Trials Market, by Phase, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global In Silico Clinical Trials Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global In Silico Clinical Trials Market Dynamics

3.1. In Silico Clinical Trials Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Reduction in the chances of adverse reactions during trials

3.1.1.2. High cost associated with traditional clinical trials

3.1.2. Market Challenges

3.1.2.1. High cost of methods and expensive procedures

3.1.3. Market Opportunities

3.1.3.1. Growth in R&D spending

3.1.3.2. Technological advancements in in silico clinical trials

Chapter 4. Global In Silico Clinical Trials Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global In Silico Clinical Trials Market, by Industry

6.1. Market Snapshot

6.2. Global In Silico Clinical Trials Market by Industry, Performance - Potential Analysis

6.3. Global In Silico Clinical Trials Market Estimates & Forecasts by Industry 2018-2028 (USD Billion)

6.4. In Silico Clinical Trials Market, Sub Segment Analysis

6.4.1. Medical Devices

6.4.2. Pharmaceutical

Chapter 7. Global In Silico Clinical Trials Market, by Therapeutic Area

7.1. Market Snapshot

7.2. Global In Silico Clinical Trials Market by Therapeutic Area, Performance - Potential Analysis

7.3. Global In Silico Clinical Trials Market Estimates & Forecasts by Therapeutic Area 2018-2028 (USD Billion)

7.4. In Silico Clinical Trials Market, Sub Segment Analysis

7.4.1. Oncology

7.4.2. Infectious Disease

7.4.3. Hematology

7.4.4. Cardiology

7.4.5. Dermatology

7.4.6. Neurology

7.4.7. Diabetes

7.4.8. Others

Chapter 8. Global In Silico Clinical Trials Market, by Phase

8.1. Market Snapshot

8.2. Global In Silico Clinical Trials Market by Phase, Performance - Potential Analysis

8.3. Global In Silico Clinical Trials Market Estimates & Forecasts by Phase 2018-2028 (USD Billion)

8.4. In Silico Clinical Trials Market, Sub Segment Analysis

8.4.1. Phase I

8.4.2. Phase II

8.4.3. Phase III

8.4.4. Phase IV

Chapter 9. Global In Silico Clinical Trials Market, Regional Analysis

9.1. In Silico Clinical Trials Market, Regional Market Snapshot

9.2. North America In Silico Clinical Trials Market

9.2.1. U.S. In Silico Clinical Trials Market

9.2.1.1. Industry breakdown estimates & forecasts, 2018-2028

9.2.1.2. Therapeutic Area breakdown estimates & forecasts, 2018-2028

9.2.1.3. Phase breakdown estimates & forecasts, 2018-2028

9.2.2. Canada In Silico Clinical Trials Market

9.3. Europe In Silico Clinical Trials Market Snapshot

9.3.1. U.K. In Silico Clinical Trials Market

9.3.2. Germany In Silico Clinical Trials Market

9.3.3. France In Silico Clinical Trials Market

9.3.4. Spain In Silico Clinical Trials Market

9.3.5. Italy In Silico Clinical Trials Market

9.3.6. Rest of Europe In Silico Clinical Trials Market

9.4. Asia-Pacific In Silico Clinical Trials Market Snapshot

9.4.1. China In Silico Clinical Trials Market

9.4.2. India In Silico Clinical Trials Market

9.4.3. Japan In Silico Clinical Trials Market

9.4.4. Australia In Silico Clinical Trials Market

9.4.5. South Korea In Silico Clinical Trials Market

9.4.6. Rest of Asia Pacific In Silico Clinical Trials Market

9.5. Latin America In Silico Clinical Trials Market Snapshot

9.5.1. Brazil In Silico Clinical Trials Market

9.5.2. Mexico In Silico Clinical Trials Market

9.6. Rest of The World In Silico Clinical Trials Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Certara, Inc.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Industry Summary

10.2.1.5. Recent Developments

10.2.2. Novadiscovery Sas

10.2.3. Insilico Medicine, Inc.

10.2.4. Dassault Systemes SE

10.2.5. GNS Healthcare Inc.

10.2.6. The AnyLogic Company

10.2.7. InSilicoTrials

10.2.8. Immunetrics Inc.

10.2.9. Nuventra Pharma Sciences

10.2.10. Abzena Ltd.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global In Silico Clinical Trials Market, report scope

TABLE 2. Global In Silico Clinical Trials Market estimates & forecasts by Region 2018-2028 (USD Billion)

TABLE 3. Global In Silico Clinical Trials Market estimates & forecasts by Industry 2018-2028 (USD Billion)

TABLE 4. Global In Silico Clinical Trials Market estimates & forecasts by Therapeutic Area 2018-2028 (USD Billion)

TABLE 5. Global In Silico Clinical Trials Market estimates & forecasts by Phase 2018-2028 (USD Billion)

TABLE 6. Global In Silico Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 7. Global In Silico Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 8. Global In Silico Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 9. Global In Silico Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 10. Global In Silico Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 11. Global In Silico Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 12. Global In Silico Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 13. Global In Silico Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 14. Global In Silico Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 15. Global In Silico Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 16. U.S. In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 17. U.S. In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 18. U.S. In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 19. Canada In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 20. Canada In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 21. Canada In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 22. UK In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 23. UK In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 24. UK In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 25. Germany In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 26. Germany In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 27. Germany In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 28. RoE In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 29. RoE In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 30. RoE In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 31. China In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 32. China In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 33. China In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 34. India In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 35. India In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 36. India In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 37. Japan In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 38. Japan In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 39. Japan In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 40. RoAPAC In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 41. RoAPAC In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 42. RoAPAC In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 43. Brazil In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 44. Brazil In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 45. Brazil In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 46. Mexico In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 47. Mexico In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 48. Mexico In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 49. RoLA In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 50. RoLA In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 51. RoLA In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 52. Row In Silico Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 53. Row In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 54. Row In Silico Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 55. List of secondary sources, used in the study of Global In Silico Clinical Trials Market

TABLE 56. List of primary sources, used in the study of Global In Silico Clinical Trials Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research